News
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...
16d
The Hearty Soul on MSNA New Ozempic-like drug Side Effect Has Just Been Discovered-And It's Turning Lives Upside DownMedications such as Ozempic and Saxenda have grown in popularity due to their ability to treat type 2 diabetes and assist in ...
How Ozempic Is Changing Diabetes Treatment Millions of patients rely on insulin. But with new drugs, some have been able to lower their doses or stop taking it altogether.
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...
Ozempic-like drugs used to treat type 2 diabetes and obesity may also treat migraine, even when the medications don't trigger weight loss, early research suggests. A preliminary report, published ...
* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...
Headaches are a common and frustrating side effect some people experience while taking the popular weight loss drug Ozempic, but the medication itself may not be to blame. According to fitness and ...
Also on Thursday, Amneal said it received FDA approval for its GLP-1 agonist -- a synthetic version of the hormone that regulates blood sugar, digestion and appetite, such as Ozempic and Rybelsus.
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...
A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study showing the GLP-1 receptor agonist provided significant relief to sufferers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results